Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Observation × Plasma cell × Clear all

Status

Completed 3 Unknown 2 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 18 Thoracic 6 Gynecologic 6 Breast 6 Lymphoid 5 Head & Neck 5 Sarcoma 4 CNS 4 Tumor-Agnostic 3 Genitourinary 3 Other hematologic neoplasm 2 Other 2 Dermatologic 2 Plasma cell 1 Other solid neoplasm 1 Endocrine 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 79 daratumumab 47 Lenalidomide 46 Cyclophosphamide 28 Bortezomib 28 pomalidomide 27 Calcium Dobesilate 23 carfilzomib 21 fludarabine 18 talquetamab 17 Specimen Handling 17 Magnetic Resonance Spectroscopy 16 iberdomide 15 Biopsy 15 isatuximab 14 belantamab mafodotin 14 dexamethasone acetate 11 selinexor 10 dexamethasone 21-phosphate 10 auricularum 10 venetoclax 9 elotuzumab 9 X-Rays 8 Melphalan 8 ixazomib 6 fludarabine phosphate 5 Phantoms, Imaging 5 Blood Specimen Collection 5 tocilizumab 4 pegylated granulocyte colony-stimulating factor 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05001087 2025-02-27

MY MYELOMA

Fondazione EMN Italy Onlus

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡